The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1993) · Nature · doi:10.1038/364033a0 · Cited by 2,379
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1994) · Nature · doi:10.1038/368215a0 · Cited by 1,555
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Epitope spreading in immune-mediated diseases: implications for immunotherapy
Vanderlugt, C. L., & Miller, S. D. (2002) · Nature Reviews Immunology · doi:10.1038/nri724 · Cited by 950
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., & Strominger, J. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.27 · Cited by 887
Dominance and Crypticity of T Cell Antigenic Determinants
Sercarz, E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.729 · Cited by 855
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J., & Enk, A. H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020394 · Cited by 603
Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.617 · Cited by 468
Knutson, K. L., Schiffman, K., & Disis, M. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11752 · Cited by 439
Self-citationDisis, M. L., Gooley, T. A., Rinn, K., Davis, D., Piepkorn, M., Cheever, M. A., Knutson, K. L., & Schiffman, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.171 · Cited by 423
Self-citationThomas, W. D., & Hersey, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2195 · Cited by 326
Antigen presentation by MHC class I and its regulation by interferon γ
Früh, K., & Yang, Y. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80014-4 · Cited by 297
Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., & Sinigaglia, F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2353 · Cited by 290
Butterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D. K., Wang, H.-J., Elashoff, R. M., McBride, W. H., Mukherji, B., et al. (2003) · PubMed · Cited by 255
Knutson, K. L., Schiffman, K., Cheever, M. A., & Disis, M. L. (2002) · PubMed · Cited by 253
Self-citationGnjatic, S., Atanackovic, D., Jäger, E., Matsuo, M., Selvakumar, A., Altorki, N. K., Maki, R. G., Dupont, B., Ritter, G., Chen, Y.-T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133324100 · Cited by 203
Induction of anti-self-immunity to cure cancer
Nanda, N. K., & Sercarz, E. E. (1995) · Cell · doi:10.1016/0092-8674(95)90047-0 · Cited by 196
Neural network-based prediction of candidate T-cell epitopes
Honeyman, M. C., Brusic, V., Stone, N. L., & Harrison, L. C. (1998) · Nature Biotechnology · doi:10.1038/nbt1098-966 · Cited by 176
Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen
Surman, D. R., Dudley, M. E., Overwijk, W. W., & Restifo, N. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.562 · Cited by 172
GAO, F. G., Khammanivong, V., Liu, W. J., Leggatt, G. R., Frazer, I. H., & Fernando, G. J. P. (2002) · PubMed · Cited by 144
Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
Kobayashi, H., Wood, M., Song, Y., Appella, E., & Celis, E. (2000) · PubMed · Cited by 139
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
Tsung, K., Dolan, J. P., Tsung, Y. L., & Norton, J. A. (2002) · PubMed · Cited by 129
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy
Gross, D., Graff‐Dubois, S., Opolon, P., Cornet, S., Alves, P. M. S., Griscelli, A. B., Faure, O., Guillaume, P., Firat, H., Chouaı̈b, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19418 · Cited by 129
Disis, M. L., Vivian Goodell, A., Schiffman, K., & Knutson, K. L. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000040928.67495.52 · Cited by 117
Self-citationZeng, G., Li, Y., El‐Gamil, M., Sidney, J., Sette, A., Wang, R. F., Rosenberg, S. A., & Robbins, P. F. (2002) · PubMed · Cited by 114
Lespagnard, L., Gancberg, D., Rouas, G., Leclercq, G., Somerhausen, N. D. S.-A., Leo, A. D., Piccart, M. J., Verhest, A. P., & Larsimont, D. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3 · Cited by 113
Consogno, G., Manici, S., Facchinetti, V., Bachi, A., Hammer, J., Conti‐Fine, B. M., Rugarli, C., Traversari, C., & Protti, M. P. (2003) · Blood · doi:10.1182/blood-2002-03-0933 · Cited by 103
Giuntoli, R. L., Lu, J., Kobayashi, H., Kennedy, R. B., & Celis, E. (2002) · PubMed · Cited by 95
Fallarino, F., Grohmann, U., Bianchi, R., Vacca, C., Fioretti, M. C., & Puccetti, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5495 · Cited by 93
Importance of CD4+ T helper cell responses in tumor immunity
OSSENDORP, F. A., Toes, R. E. M., Offringa, R., van der Burg, S. H., & Melief, C. J. M. (2000) · Immunology Letters · doi:10.1016/s0165-2478(00)00252-2 · Cited by 92
Therapy with cultured T cells: principles revisited
Cheever, M. A., & Chen, W. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00982.x · Cited by 89
Schroers, R., Shen, L., Rollins, L. A., Rooney, C. M., Slawin, K. M., Sønderstrup, G., Huang, X. F., & Chen, S. (2003) · PubMed · Cited by 87
Driver Clones and Determinant Spreading
Sercarz, E. E. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0380 · Cited by 81
Identifying antigenic T-cell sites
Feller, D. C., & de la Cruz, V. F. (1991) · Nature · doi:10.1038/349720a0 · Cited by 67
Campi, G., Crosti, M., Consogno, G., Facchinetti, V., Conti‐Fine, B. M., Longhi, R., Casorati, G., Dellabona, P., & Protti, M. P. (2003) · PubMed · Cited by 59
TAP-Independent Presentation of CTL Epitopes by Trojan Antigens
Lu, J., Wettstein, P. J., Higashimoto, Y., Appella, E., & Celis, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7063 · Cited by 55
Wroblewski, J. M., Bixby, D. L., Borowski, C., & Yannelli, J. R. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00210-0 · Cited by 53
Evaluation of HLA-DR Expression and T-Lymphocyte Infiltration in Osteosarcoma
Trieb, K., Lechleitner, T., Lang, S., Windhager, R. H., Kotz, R. I., & Dirnhofer, S. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80126-x · Cited by 52
Koivisto, P. A., & Rantala, I. S. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199901)187:2<191::aid-path206>3.0.co;2-3 · Cited by 49
Perez, S. A., Sotiropoulou, P. A., Sotiriadou, N. N., Mamalaki, A., Gritzapis, A. D., Echner, H., Voelter, W., Pawelec, G., Papamichail, M., & Baxevanis, C. N. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s002620100225 · Cited by 49
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Altomonte, M., Fonsatti, E., Visintin, A., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206960 · Cited by 48
Ii-Key/HER-2/ neu MHC class-II antigenic epitope vaccine peptide for breast cancer
Gillogly, M., Kallinteris, N. L., Xu, M., Gulfo, J. V., Humphreys, R. E., & Murray, J. L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0463-y · Cited by 48
Concha, Á., Ruiz‐Cabello, F., Cabrera, T., Nogales, F. F., Collado, A., & Garrido, F. (1995) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1995.tb00246.x · Cited by 35
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
Metadata
- Authors
- Knutson, K. L., & Disis, M. L.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2005-01-27
- Volume
- 54
- Issue
- 8
- Pages
- 721-728
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2154203858
- Cited by
- 682
- References
- 47
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.